US Stock MarketDetailed Quotes

MIRA MIRA Pharmaceuticals

Watchlist
  • 1.200
  • +0.030+2.56%
Close May 6 16:00 ET
  • 1.210
  • +0.010+0.83%
Post 19:58 ET
20.18MMarket Cap-2.35P/E (TTM)

MIRA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-38.45%2.83M
-38.45%2.83M
-29.37%4.14M
11,275.66%2.82M
261,478.58%3.53M
1,211.35%4.6M
1,211.35%4.6M
--5.87M
--24.82K
--1.35K
-Cash and cash equivalents
-38.45%2.83M
-38.45%2.83M
-29.37%4.14M
11,275.66%2.82M
261,478.58%3.53M
1,211.35%4.6M
1,211.35%4.6M
--5.87M
--24.82K
--1.35K
Receivables
--0
--0
--0
--0
--0
--11.86K
--11.86K
----
----
----
-Other receivables
----
----
----
----
----
--11.86K
--11.86K
----
----
----
Prepaid assets
-77.55%54.73K
-77.55%54.73K
-57.32%86.57K
155.44%108.62K
208.73%185.34K
--243.8K
--243.8K
--202.82K
--42.52K
--60.03K
Current deferred assets
----
----
----
----
----
----
----
--0
--353.37K
--189.69K
Total current assets
-40.56%2.89M
-40.56%2.89M
-30.31%4.23M
597.00%2.93M
1,379.29%3.71M
882.64%4.86M
882.64%4.86M
--6.07M
--420.72K
--251.07K
Non current assets
Net PPE
--0
--0
--0
--0
-99.13%1.27K
-98.61%5.06K
-98.61%5.06K
--114.36K
--132.33K
--146.51K
-Gross PPE
--0
--0
--0
--0
-99.13%1.27K
-98.61%5.06K
-98.61%5.06K
--114.36K
--132.33K
--146.51K
Non current accounts receivable
-48.75%35.44K
-48.75%35.44K
-29.12%35.44K
66.35%83.18K
--93.49K
--69.15K
--69.15K
--50K
--50K
----
Non current deferred assets
----
----
----
----
----
----
----
--2.78M
--3.22M
----
Total non current assets
-52.25%35.44K
-52.25%35.44K
-98.80%35.44K
-97.56%83.18K
-35.32%94.76K
-79.59%74.21K
-79.59%74.21K
--2.95M
--3.4M
--146.51K
Total assets
-40.74%2.92M
-40.74%2.92M
-52.69%4.27M
-21.16%3.02M
857.99%3.81M
474.83%4.93M
474.83%4.93M
--9.02M
--3.83M
--397.58K
Liabilities
Current liabilities
Payables
34.31%723.35K
34.31%723.35K
35.67%692.83K
21.24%782.14K
-64.45%636.26K
-40.53%538.56K
-40.53%538.56K
--510.69K
--645.14K
--1.79M
-accounts payable
34.31%723.35K
34.31%723.35K
35.67%692.83K
21.24%782.14K
-30.74%636.26K
-31.76%538.56K
-31.76%538.56K
--510.69K
--645.14K
--918.62K
-Due to related parties current
----
----
----
----
----
----
----
--0
--0
--871.24K
Current accrued expenses
--0
--0
--0
-72.98%14.47K
-60.50%14.47K
-74.84%14.47K
-74.84%14.47K
--283.36K
--53.57K
--36.64K
Current debt and capital lease obligation
----
----
----
----
-99.56%1.27K
-98.76%5.06K
-98.76%5.06K
--74.33K
--1.88M
--292.35K
-Current debt
----
----
----
----
----
----
----
----
--1.8M
--219.54K
-Current capital lease obligation
--0
--0
--0
--0
-98.25%1.27K
-98.15%5.06K
-98.15%5.06K
--74.33K
--75.36K
--72.81K
Current liabilities
29.61%723.35K
29.61%723.35K
-20.21%692.83K
-69.09%796.61K
-69.23%652.01K
-59.26%558.1K
-59.26%558.1K
--868.37K
--2.58M
--2.12M
Non current liabilities
Long term debt and capital lease obligation
----
----
----
----
----
----
----
--34.53K
--51.47K
--68.21K
-Long term capital lease obligation
----
----
----
----
----
----
----
--34.53K
--51.47K
--68.21K
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--34.53K
--51.47K
--68.21K
Total liabilities
29.61%723.35K
29.61%723.35K
-23.27%692.83K
-69.69%796.61K
-70.19%652.01K
-61.62%558.1K
-61.62%558.1K
--902.9K
--2.63M
--2.19M
Shareholders'equity
Share capital
12.04%1.66K
12.04%1.66K
10.08%1.63K
-77.80%1.48K
-77.80%1.48K
-77.80%1.48K
-77.80%1.48K
--1.48K
--6.66K
--6.66K
-common stock
12.04%1.66K
12.04%1.66K
10.08%1.63K
-77.80%1.48K
-77.80%1.48K
-77.80%1.48K
-77.80%1.48K
--1.48K
--6.66K
--6.66K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-36.89%-29.14M
-36.89%-29.14M
-72.53%-26.74M
-107.34%-24.69M
-116.12%-23M
-128.80%-21.29M
-128.80%-21.29M
---15.5M
---11.91M
---10.64M
Paid-in capital
22.13%31.34M
22.13%31.34M
28.37%30.31M
105.44%26.91M
195.65%26.16M
194.92%25.66M
194.92%25.66M
--23.61M
--13.1M
--8.85M
Total stockholders'equity
-49.71%2.2M
-49.71%2.2M
-55.96%3.57M
85.44%2.22M
276.41%3.16M
833.67%4.37M
833.67%4.37M
--8.12M
--1.2M
---1.79M
Total equity
-49.71%2.2M
-49.71%2.2M
-55.96%3.57M
85.44%2.22M
276.41%3.16M
833.67%4.37M
833.67%4.37M
--8.12M
--1.2M
---1.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -38.45%2.83M-38.45%2.83M-29.37%4.14M11,275.66%2.82M261,478.58%3.53M1,211.35%4.6M1,211.35%4.6M--5.87M--24.82K--1.35K
-Cash and cash equivalents -38.45%2.83M-38.45%2.83M-29.37%4.14M11,275.66%2.82M261,478.58%3.53M1,211.35%4.6M1,211.35%4.6M--5.87M--24.82K--1.35K
Receivables --0--0--0--0--0--11.86K--11.86K------------
-Other receivables ----------------------11.86K--11.86K------------
Prepaid assets -77.55%54.73K-77.55%54.73K-57.32%86.57K155.44%108.62K208.73%185.34K--243.8K--243.8K--202.82K--42.52K--60.03K
Current deferred assets ------------------------------0--353.37K--189.69K
Total current assets -40.56%2.89M-40.56%2.89M-30.31%4.23M597.00%2.93M1,379.29%3.71M882.64%4.86M882.64%4.86M--6.07M--420.72K--251.07K
Non current assets
Net PPE --0--0--0--0-99.13%1.27K-98.61%5.06K-98.61%5.06K--114.36K--132.33K--146.51K
-Gross PPE --0--0--0--0-99.13%1.27K-98.61%5.06K-98.61%5.06K--114.36K--132.33K--146.51K
Non current accounts receivable -48.75%35.44K-48.75%35.44K-29.12%35.44K66.35%83.18K--93.49K--69.15K--69.15K--50K--50K----
Non current deferred assets ------------------------------2.78M--3.22M----
Total non current assets -52.25%35.44K-52.25%35.44K-98.80%35.44K-97.56%83.18K-35.32%94.76K-79.59%74.21K-79.59%74.21K--2.95M--3.4M--146.51K
Total assets -40.74%2.92M-40.74%2.92M-52.69%4.27M-21.16%3.02M857.99%3.81M474.83%4.93M474.83%4.93M--9.02M--3.83M--397.58K
Liabilities
Current liabilities
Payables 34.31%723.35K34.31%723.35K35.67%692.83K21.24%782.14K-64.45%636.26K-40.53%538.56K-40.53%538.56K--510.69K--645.14K--1.79M
-accounts payable 34.31%723.35K34.31%723.35K35.67%692.83K21.24%782.14K-30.74%636.26K-31.76%538.56K-31.76%538.56K--510.69K--645.14K--918.62K
-Due to related parties current ------------------------------0--0--871.24K
Current accrued expenses --0--0--0-72.98%14.47K-60.50%14.47K-74.84%14.47K-74.84%14.47K--283.36K--53.57K--36.64K
Current debt and capital lease obligation -----------------99.56%1.27K-98.76%5.06K-98.76%5.06K--74.33K--1.88M--292.35K
-Current debt ----------------------------------1.8M--219.54K
-Current capital lease obligation --0--0--0--0-98.25%1.27K-98.15%5.06K-98.15%5.06K--74.33K--75.36K--72.81K
Current liabilities 29.61%723.35K29.61%723.35K-20.21%692.83K-69.09%796.61K-69.23%652.01K-59.26%558.1K-59.26%558.1K--868.37K--2.58M--2.12M
Non current liabilities
Long term debt and capital lease obligation ------------------------------34.53K--51.47K--68.21K
-Long term capital lease obligation ------------------------------34.53K--51.47K--68.21K
Total non current liabilities --0--0--0--0--0--0--0--34.53K--51.47K--68.21K
Total liabilities 29.61%723.35K29.61%723.35K-23.27%692.83K-69.69%796.61K-70.19%652.01K-61.62%558.1K-61.62%558.1K--902.9K--2.63M--2.19M
Shareholders'equity
Share capital 12.04%1.66K12.04%1.66K10.08%1.63K-77.80%1.48K-77.80%1.48K-77.80%1.48K-77.80%1.48K--1.48K--6.66K--6.66K
-common stock 12.04%1.66K12.04%1.66K10.08%1.63K-77.80%1.48K-77.80%1.48K-77.80%1.48K-77.80%1.48K--1.48K--6.66K--6.66K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -36.89%-29.14M-36.89%-29.14M-72.53%-26.74M-107.34%-24.69M-116.12%-23M-128.80%-21.29M-128.80%-21.29M---15.5M---11.91M---10.64M
Paid-in capital 22.13%31.34M22.13%31.34M28.37%30.31M105.44%26.91M195.65%26.16M194.92%25.66M194.92%25.66M--23.61M--13.1M--8.85M
Total stockholders'equity -49.71%2.2M-49.71%2.2M-55.96%3.57M85.44%2.22M276.41%3.16M833.67%4.37M833.67%4.37M--8.12M--1.2M---1.79M
Total equity -49.71%2.2M-49.71%2.2M-55.96%3.57M85.44%2.22M276.41%3.16M833.67%4.37M833.67%4.37M--8.12M--1.2M---1.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Petroleo Brasileiro SA Petrobras
PBR
11.300
Adobe
ADBE
382.980
MARA Holdings
MARA
13.150
4
Salesforce
CRM
273.360
5
Vale SA
VALE
9.310
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀